68Ga-FAPI is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Peking Union Medical College Hospital (1) and Zhongnan Hospital (1). Registered phases: Phase 1/2 and Not applicable. Conditions studied include Sjogren's Syndrome; Fibroblast Activation Protein Inhibitor; PET/CT.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07062523 | Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT (ClinicalTrials.gov ↗) Sjogren's Syndrome |
Phase 1/2 | Recruiting |
| NCT05034146 | 68Ga-FAPI PET/CT in Malignant Tumors (ClinicalTrials.gov ↗) Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Sjogren's Syndrome | 1 |
| Fibroblast Activation Protein Inhibitor | 1 |
| PET/CT | 1 |
| Malignant Neoplasm | 1 |
| Lead sponsor | Trials |
|---|---|
| Peking Union Medical College Hospital | 1 |
| Zhongnan Hospital | 1 |
| Register | 68Ga-FAPI trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how 68Ga-FAPI works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists 68Ga-FAPI (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.